Business Context and Reporting Period
Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2005
Business Overview: NAI provides private label contract manufacturing services for nutritional supplements. The company operates primarily in the United States and Europe (via subsidiary NAIE). Revenue is heavily dependent on two major customers in the direct sales marketing channel, who accounted for 83% of total net sales in the quarter.
Key Financial Metrics
| Metric (in thousands) | Q3 2005 | Q3 2004 |
|---|---|---|
| Net Sales | $21,733 | $22,727 |
| Gross Profit | $4,056 | $5,318 |
| Gross Margin | 18.7% | 23.4% |
| Operating Income | $678 | $1,394 |
| Net Income | $412 | $852 |
| Diluted EPS | $0.06 | $0.13 |
| Operating Cash Flow | $3,849 | $(1,571) |
| Cash and Equivalents (End of Period) | $5,585 | $3,204 |
| Total Debt | $3,642 | N/A |
Note: Total debt calculated as current portion ($870) + long-term debt ($2,772). Q3 2004 debt figures not explicitly summarized in the text provided.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 4% year-over-year. This was driven by a 7% reduction in sales to Mannatech, Inc. and the discontinuation of two customer relationships, partially offset by a 10% increase in sales to NSA International, Inc.
- Margin Compression: Gross profit margin fell 4.7 percentage points to 18.7%. Key drivers included incremental overhead expenses ($286,000) related to facility expansion and regulatory testing, higher inventory reserves, and increased labor costs due to a shift toward lower-priced products.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased 14% ($546,000) due to personnel reductions, lower clinical study costs, and reduced incentive plan payouts, partially offset by $84,000 in litigation expenses.
- Cash Flow Improvement: Operating cash flow turned positive ($3.8M) compared to a negative $1.6M in the prior year, primarily due to a $4.9M reduction in accounts receivable.
Guidance, Outlook, and Risks
- Outlook: Management anticipates a further decline in contract manufacturing revenue in the second quarter of fiscal 2006. The company is actively reducing its cost structure to maintain profitability.
- Growth Initiatives: NAI has received initial orders from two new direct sales customers and is evaluating an acquisition to diversify its customer base and add branded product lines. A new direct mail campaign for proprietary products was launched in October 2005.
- Customer Concentration Risk: The top two customers represent 83% of net sales. The loss of either customer would have a material adverse impact on the business.
- Legal Contingency: A patent infringement lawsuit filed by Novogen Research Pty. Ltd. is being settled for a one-time payment of $75,000.
- Market Risk: The company is exposed to foreign currency fluctuations (Euro and Swiss Franc). A 10% adverse change in exchange rates would decrease net income by approximately $79,000 for the quarter.
Investor Verification Checklist
- Customer Dependency: Verify the stability of relationships with the top two customers (NSA International and Mannatech), which drive 83% of revenue.
- Margin Sustainability: Assess whether the 18.7% gross margin is sustainable given the shift to lower-priced products and increased overhead from facility expansion.
- New Customer Ramp-up: Monitor the volume and profitability of the two new direct sales customers mentioned in the outlook.
- Debt Covenants: Review the $12.0 million credit facility terms, noting that additional indebtedness requires lender approval.
- Legal Settlement: Confirm the finalization and payment of the $75,000 Novogen settlement.